Free Trial

Drugs Made In America Acquisition II (DMII) Competitors

Drugs Made In America Acquisition II logo
$10.08 0.00 (0.00%)
Closing price 06/8/2026 04:00 PM Eastern
Extended Trading
$10.09 +0.01 (+0.05%)
As of 06/8/2026 04:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

DMII vs. ONCHU, ONCHW, ASPCU, AACOU, and ACGCU

Should you buy Drugs Made In America Acquisition II stock or one of its competitors? MarketBeat compares Drugs Made In America Acquisition II with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Drugs Made In America Acquisition II include 1RT Acquisition (ONCHU), 1RT Acquisition (ONCHW), A SPAC III Acquisition (ASPCU), Abony Acquisition Corp I (AACOU), and ACP Holdings Acquisition (ACGCU). These companies are all part of the "trading" industry.

How does Drugs Made In America Acquisition II compare to 1RT Acquisition?

Drugs Made In America Acquisition II (NASDAQ:DMII) and 1RT Acquisition (NASDAQ:ONCHU) are both financial services companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, profitability, analyst recommendations, dividends, media sentiment and risk.

In the previous week, Drugs Made In America Acquisition II's average media sentiment score of 0.00 equaled 1RT Acquisition'saverage media sentiment score.

Company Overall Sentiment
Drugs Made In America Acquisition II Neutral
1RT Acquisition Neutral

Company Net Margins Return on Equity Return on Assets
Drugs Made In America Acquisition IIN/A N/A N/A
1RT Acquisition N/A N/A N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Drugs Made In America Acquisition II
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
1RT Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Drugs Made In America Acquisition IIN/AN/AN/AN/AN/A
1RT AcquisitionN/AN/AN/AN/AN/A

Summary

Drugs Made In America Acquisition II beats 1RT Acquisition on 1 of the 1 factors compared between the two stocks.

How does Drugs Made In America Acquisition II compare to 1RT Acquisition?

1RT Acquisition (NASDAQ:ONCHW) and Drugs Made In America Acquisition II (NASDAQ:DMII) are both financial services companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, dividends, analyst recommendations, risk, institutional ownership, earnings, media sentiment and valuation.

Company Net Margins Return on Equity Return on Assets
1RT AcquisitionN/A N/A N/A
Drugs Made In America Acquisition II N/A N/A N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
1RT Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Drugs Made In America Acquisition II
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
1RT AcquisitionN/AN/AN/AN/AN/A
Drugs Made In America Acquisition IIN/AN/AN/AN/AN/A

In the previous week, 1RT Acquisition's average media sentiment score of 0.00 equaled Drugs Made In America Acquisition II'saverage media sentiment score.

Company Overall Sentiment
1RT Acquisition Neutral
Drugs Made In America Acquisition II Neutral

Summary

Drugs Made In America Acquisition II beats 1RT Acquisition on 1 of the 1 factors compared between the two stocks.

How does Drugs Made In America Acquisition II compare to A SPAC III Acquisition?

A SPAC III Acquisition (NASDAQ:ASPCU) and Drugs Made In America Acquisition II (NASDAQ:DMII) are both investment offices industry companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, profitability, analyst recommendations, institutional ownership, valuation and dividends.

Company Net Margins Return on Equity Return on Assets
A SPAC III AcquisitionN/A N/A N/A
Drugs Made In America Acquisition II N/A N/A N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
A SPAC III Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Drugs Made In America Acquisition II
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
A SPAC III AcquisitionN/AN/AN/AN/AN/A
Drugs Made In America Acquisition IIN/AN/AN/AN/AN/A

In the previous week, A SPAC III Acquisition's average media sentiment score of 0.00 equaled Drugs Made In America Acquisition II'saverage media sentiment score.

Company Overall Sentiment
A SPAC III Acquisition Neutral
Drugs Made In America Acquisition II Neutral

Summary

Drugs Made In America Acquisition II beats A SPAC III Acquisition on 1 of the 1 factors compared between the two stocks.

How does Drugs Made In America Acquisition II compare to Abony Acquisition Corp I?

Abony Acquisition Corp I (NASDAQ:AACOU) and Drugs Made In America Acquisition II (NASDAQ:DMII) are both financial services companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, media sentiment, earnings, profitability, valuation, analyst recommendations, institutional ownership and risk.

Company Net Margins Return on Equity Return on Assets
Abony Acquisition Corp IN/A N/A N/A
Drugs Made In America Acquisition II N/A N/A N/A

In the previous week, Abony Acquisition Corp I's average media sentiment score of 0.00 equaled Drugs Made In America Acquisition II'saverage media sentiment score.

Company Overall Sentiment
Abony Acquisition Corp I Neutral
Drugs Made In America Acquisition II Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Abony Acquisition Corp I
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Drugs Made In America Acquisition II
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abony Acquisition Corp IN/AN/AN/AN/AN/A
Drugs Made In America Acquisition IIN/AN/AN/AN/AN/A

Summary

Drugs Made In America Acquisition II beats Abony Acquisition Corp I on 1 of the 1 factors compared between the two stocks.

How does Drugs Made In America Acquisition II compare to ACP Holdings Acquisition?

Drugs Made In America Acquisition II (NASDAQ:DMII) and ACP Holdings Acquisition (NASDAQ:ACGCU) are both financial services companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, earnings, risk, analyst recommendations, institutional ownership, media sentiment and dividends.

In the previous week, Drugs Made In America Acquisition II's average media sentiment score of 0.00 equaled ACP Holdings Acquisition'saverage media sentiment score.

Company Overall Sentiment
Drugs Made In America Acquisition II Neutral
ACP Holdings Acquisition Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Drugs Made In America Acquisition II
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
ACP Holdings Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Company Net Margins Return on Equity Return on Assets
Drugs Made In America Acquisition IIN/A N/A N/A
ACP Holdings Acquisition N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Drugs Made In America Acquisition IIN/AN/AN/AN/AN/A
ACP Holdings AcquisitionN/AN/AN/AN/AN/A

Summary

Drugs Made In America Acquisition II beats ACP Holdings Acquisition on 1 of the 1 factors compared between the two stocks.

Get Drugs Made In America Acquisition II News Delivered to You Automatically

Sign up to receive the latest news and ratings for DMII and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DMII vs. The Competition

MetricDrugs Made In America Acquisition IIInvestment Offices IndustryFinancial SectorNASDAQ Exchange
Market CapN/A$317.76M$5.71B$11.99B
Dividend YieldN/AN/A5.28%5.58%
P/E RatioN/A2.2316.3523.74
Price / SalesN/A195.461,132.49119.88
Price / CashN/A136.5248.6837.25
Price / BookN/A347.216.486.78
Net IncomeN/A-$66.73M$1.13B$337.51M
7 Day Performance0.15%-0.05%-0.61%-2.34%
1 Month Performance0.70%3.79%0.69%1.88%
1 Year PerformanceN/A8.32%18.67%25.55%

Drugs Made In America Acquisition II Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DMII
Drugs Made In America Acquisition II
N/A$10.08
flat
N/AN/A$0.00N/AN/A2
ONCHU
1RT Acquisition
N/A$10.33
0.0%
N/AN/A$0.00N/AN/A2
ONCHW
1RT Acquisition
N/A$0.49
+8.9%
N/AN/A$0.00N/AN/A2
ASPCU
A SPAC III Acquisition
N/A$11.05
-7.9%
N/AN/A$0.00N/AN/AN/A
AACOU
Abony Acquisition Corp I
N/A$10.42
+4.0%
N/AN/A$0.00N/AN/A2

Related Companies and Tools


This page (NASDAQ:DMII) was last updated on 6/9/2026 by MarketBeat.com Staff.
From Our Partners